37.70
price up icon1.11%   0.395
 
loading
Royalty Pharma Plc stock is traded at $37.70, with a volume of 2.96M. It is up +1.11% in the last 24 hours and up +4.56% over the past month. Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
See More
Previous Close:
$37.30
Open:
$37.06
24h Volume:
2.96M
Relative Volume:
0.78
Market Cap:
$16.30B
Revenue:
$2.31B
Net Income/Loss:
$1.66B
P/E Ratio:
16.41
EPS:
2.297
Net Cash Flow:
$827.02M
1W Performance:
+3.58%
1M Performance:
+4.56%
6M Performance:
+14.67%
1Y Performance:
+38.66%
1-Day Range:
Value
$36.76
$38.09
1-Week Range:
Value
$36.23
$38.09
52-Week Range:
Value
$24.05
$38.09

Royalty Pharma Plc Stock (RPRX) Company Profile

Name
Name
Royalty Pharma Plc
Name
Phone
(212) 883-0200
Name
Address
110 EAST 59TH STREET, NEW YORK, NY
Name
Employee
99
Name
Twitter
Name
Next Earnings Date
2025-02-11
Name
Latest SEC Filings
Name
RPRX's Discussions on Twitter

Compare RPRX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
RPRX
Royalty Pharma Plc
37.70 16.12B 2.31B 1.66B 827.02M 2.297
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
425.41 109.22B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
629.07 67.50B 14.25B 4.58B 3.88B 41.77
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
424.19 57.35B 3.21B 43.57M 221.36M 0.2405
Biotechnology icon
ARGX
Argen X Se Adr
837.14 50.87B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
INSM
Insmed Inc
183.80 39.72B 447.02M -1.18B -868.57M -6.1812

Royalty Pharma Plc Stock (RPRX) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-30-25 Initiated Goldman Buy
May-16-25 Initiated Morgan Stanley Overweight
Jun-03-24 Downgrade UBS Buy → Neutral
Jun-14-22 Resumed UBS Buy
May-13-22 Initiated Scotiabank Sector Outperform
Apr-27-22 Initiated Goldman Buy
Apr-14-22 Upgrade JP Morgan Neutral → Overweight
Apr-06-22 Resumed Morgan Stanley Overweight
Oct-29-21 Upgrade Citigroup Neutral → Buy
Jul-30-21 Initiated Tigress Financial Buy
Nov-09-20 Upgrade UBS Neutral → Buy
Jul-14-20 Initiated Evercore ISI In-line
Jul-13-20 Initiated BofA Securities Buy
Jul-13-20 Initiated Citigroup Neutral
Jul-13-20 Initiated Cowen Outperform
Jul-13-20 Initiated Goldman Neutral
Jul-13-20 Initiated JP Morgan Neutral
Jul-13-20 Initiated Morgan Stanley Equal-Weight
Jul-13-20 Initiated SunTrust Buy
Jul-13-20 Initiated UBS Neutral
View All

Royalty Pharma Plc Stock (RPRX) Latest News

pulisher
11:26 AM

Royalty Pharma stock hits 52-week high at 38.01 USD - Investing.com

11:26 AM
pulisher
08:07 AM

Royalty Pharma acquires AMVUTTRA royalty interest for $310 million - Investing.com

08:07 AM
pulisher
07:21 AM

Royalty Pharma Acquires $310 Million Royalty Interest in Alnylam's AMVUTTRA from Blackstone Life Sciences - Quiver Quantitative

07:21 AM
pulisher
07:17 AM

Royalty Pharma acquires AMVUTTRA royalty for $310 million - StreetInsider

07:17 AM
pulisher
07:15 AM

Royalty Pharma (NASDAQ: RPRX) acquires 1% AMVUTTRA royalty for $310M from Blackstone - Stock Titan

07:15 AM
pulisher
06:36 AM

Is Royalty Pharma plc reversing from oversold territory2025 Market Outlook & Capital Efficient Trade Techniques - newser.com

06:36 AM
pulisher
06:11 AM

Quantitative breakdown of Royalty Pharma plc recent moveTrade Signal Summary & Real-Time Stock Price Movement Reports - newser.com

06:11 AM
pulisher
05:48 AM

Corton Capital Inc. Acquires New Holdings in Royalty Pharma PLC $RPRX - MarketBeat

05:48 AM
pulisher
05:00 AM

Can Royalty Pharma plc stock rebound after recent weaknessEarnings Miss & Consistent Profit Trading Strategies - newser.com

05:00 AM
pulisher
04:57 AM

Applying chart zones and confluence areas to Royalty Pharma plcMarket Performance Report & Fast Gain Swing Trade Alerts - newser.com

04:57 AM
pulisher
04:33 AM

Royalty Pharma PLC $RPRX Shares Purchased by Strs Ohio - MarketBeat

04:33 AM
pulisher
03:39 AM

Is Royalty Pharma plc (RPD) stock attractive post correctionExit Point & Consistent Return Investment Signals - newser.com

03:39 AM
pulisher
Nov 03, 2025

How Royalty Pharma plc (RPD) stock performs in easing cyclesForecast Cut & Long-Term Growth Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What To Expect From Royalty Pharma’s (RPRX) Q3 Earnings - Yahoo! Finance UK

Nov 03, 2025
pulisher
Nov 03, 2025

Royalty Pharma PLC $RPRX is Torray Investment Partners LLC's 3rd Largest Position - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

Tredje AP fonden Increases Stake in Royalty Pharma PLC $RPRX - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

Will Royalty Pharma plc (RPD) stock maintain strong growthPortfolio Return Report & Community Trade Idea Sharing - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Will Royalty Pharma plc (RPD) stock hit Wall Street targetsJobs Report & Weekly Breakout Opportunity Watchlist - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Royalty Pharma plc stock a top momentum playWeekly Stock Report & Weekly Setup with High ROI Potential - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What the charts say about Royalty Pharma plc today2025 Price Momentum & Scalable Portfolio Growth Methods - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Royalty Pharma plc (RPD) stock could outperform next year2025 Technical Overview & Safe Entry Trade Signal Reports - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Why Royalty Pharma plc (RPD) stock could rally stronglyStock Surge & Long-Term Safe Investment Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

What MACD signals say about Royalty Pharma plcMarket Movement Recap & Low Risk Investment Opportunities - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

8,849 Shares in Royalty Pharma PLC $RPRX Acquired by MMA Asset Management LLC - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

Royalty Pharma PLC $RPRX is Regal Partners Ltd's 9th Largest Position - MarketBeat

Nov 03, 2025
pulisher
Nov 03, 2025

Top chart patterns to watch in Royalty Pharma plcStock Surge & Risk Managed Investment Strategies - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Is Royalty Pharma plc stock a safe investment in uncertain marketsWeekly Loss Report & Reliable Intraday Trade Plans - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Royalty Pharma plc : Close to an important technical resistance levels - MarketScreener

Nov 03, 2025
pulisher
Nov 03, 2025

Why analysts remain bullish on Royalty Pharma plc stockEarnings Trend Report & AI Enhanced Trading Alerts - newser.com

Nov 03, 2025
pulisher
Nov 03, 2025

Historical volatility pattern of Royalty Pharma plc visualizedLong Setup & Risk Controlled Swing Alerts - newser.com

Nov 03, 2025
pulisher
Nov 02, 2025

Can Royalty Pharma plc stock beat analyst upgradesProfit Target & Fast Gain Swing Trade Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Detecting support and resistance levels for Royalty Pharma plcMarket Trend Report & Fast Entry Momentum Alerts - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

28,646 Shares in Royalty Pharma PLC $RPRX Bought by Nisa Investment Advisors LLC - MarketBeat

Nov 02, 2025
pulisher
Nov 02, 2025

How Royalty Pharma Prints Cash Without Biotech's Biggest Risks - MSN

Nov 02, 2025
pulisher
Nov 02, 2025

Using Python tools to backtest Royalty Pharma plc strategiesMarket Trend Report & Stock Portfolio Risk Control - newser.com

Nov 02, 2025
pulisher
Nov 02, 2025

Royalty Pharma (NASDAQ:RPRX) Upgraded by Wall Street Zen to "Buy" Rating - MarketBeat

Nov 02, 2025
pulisher
Nov 01, 2025

What drives Royalty Pharma plc stock priceMarket Sentiment Extremes & Low Risk Trading Ideas - earlytimes.in

Nov 01, 2025
pulisher
Nov 01, 2025

Royalty Pharma PLC $RPRX Shares Purchased by Fjarde AP Fonden Fourth Swedish National Pension Fund - MarketBeat

Nov 01, 2025

Royalty Pharma Plc Stock (RPRX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$28.93
price up icon 0.77%
$102.03
price up icon 0.44%
$104.44
price up icon 0.38%
biotechnology ONC
$310.18
price down icon 0.49%
$183.80
price down icon 1.37%
Cap:     |  Volume (24h):